Pharmacoeconomics of Therapeutic Drug Monitoring in Transplantation
- 1 February 2000
- journal article
- review article
- Published by Wolters Kluwer Health in Therapeutic Drug Monitoring
- Vol. 22 (1) , 36-39
- https://doi.org/10.1097/00007691-200002000-00007
Abstract
Immunosuppressive drugs have contributed significantly to the success of organ transplantation. Therapeutic drug monitoring is an integral part of transplant protocols. However, there is little information concerning its positive contribution to pharmacoeconomics. Before developing studies to demonstrate the potential benefits of TDM, consideration must be given to the type of TDM to be evaluated. It is argued that, given that the lymphocyte in the central compartment is the target for immunosuppressants, Area-Under-the-Curve monitoring may be a better reflection of control and toxicity than traditional trough monitoring.Keywords
This publication has 23 references indexed in Scilit:
- The Role of Therapeutic Drug Monitoring in Disease Management: IntroductionClinical Chemistry, 1998
- EditorialTherapeutic Drug Monitoring, 1997
- Comparison of cyclosporine monitoring with trough levels to levels obtained 6 hours after the morning dose in heart transplant patients: A prospective randomized studyTransplantation Proceedings, 1997
- Thiopurine methyltransferase activity in American white subjects and black subjectsClinical Pharmacology & Therapeutics, 1994
- Influence of cyclosporine pharmacokinetics, trough concentrations, and AUC monitoring on outcome after kidney transplantationClinical Pharmacology & Therapeutics, 1993
- Who Is Ordering All Those Cyclosporin Concentrations and How Do They Use Them? An Audit of Cyclosporin Therapeutic Drug MonitoringTherapeutic Drug Monitoring, 1993
- Cyclosporin Clinical PharmacokineticsClinical Pharmacokinetics, 1993
- Azathioprine-induced myelosuppression in thiopurine methyltransferase deficient heart transplant recipientThe Lancet, 1993
- Cyclosporine-Associated Chronic NephropathyNew England Journal of Medicine, 1984
- CYCLOSPORIN A INITIALLY AS THE ONLY IMMUNOSUPPRESSANT IN 34 RECIPIENTS OF CADAVERIC ORGANS: 32 KIDNEYS, 2 PANCREASES, AND 2 LIVERSThe Lancet, 1979